Evidence map›Paper›PMID 25147525›Full record

ArticleFrontiers in physiology2014

Na(+) current expression in human atrial myofibroblasts: identity and functional roles.

Jussi T Koivumäki, Robert B Clark, Darrell Belke, Colleen Kondo, Paul W M Fedak, Mary M C Maleckar, Wayne R Giles

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. TRPM4 non-selective cation channel in human atrial fibroblast growth.Pflugers Archiv : European journal of physiology · 2020
    Article
  10. Review
  11. Article
  12. CaBritish journal of pharmacology · 2020
    Review
  13. Article
  14. CaJournal of cardiovascular development and disease · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jussi T KoivumäkiSimula Research Laboratory, Center for Biomedical Computing and Center for Cardiological Innovation Oslo, Norway.
Robert B ClarkFaculty of Kinesiology, University of Calgary Calgary, AB, Canada.
Darrell BelkeFaculty of Kinesiology, University of Calgary Calgary, AB, Canada.
Colleen KondoFaculty of Kinesiology, University of Calgary Calgary, AB, Canada.
Paul W M FedakDivision of Cardiothoracic Surgery, Department of Cardiac Sciences, University of Calgary Calgary, AB, Canada.
Mary M C MaleckarSimula Research Laboratory, Center for Biomedical Computing and Center for Cardiological Innovation Oslo, Norway.
Wayne R GilesFaculty of Kinesiology, University of Calgary Calgary, AB, Canada.
University of Calgary · CASimula Research Laboratory · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the mammalian heart fibroblasts have important functional roles in both healthy conditions and diseased states. During pathophysiological challenges, a closely related myofibroblast cell population emerges, and can have distinct, significant roles. Recently, it has been reported that human atrial myofibroblasts can express a Na(+) current, INa. Some of the biophysical properties and molecular features suggest that this INa is due to expression of Nav 1.5, the same Na(+) channel α subunit that generates the predominant INa in myocytes from adult mammalian heart. In principle, expression of Nav 1.5 could give rise to regenerative action potentials in the fibroblasts/myofibroblasts. This would suggest an active as opposed to passive role for fibroblasts/myofibroblasts in both the "trigger" and the "substrate" components of cardiac rhythm disturbances. Our goals in this preliminary study were: (i) to confirm and extend the electrophysiological characterization of INa in a human atrial fibroblast/myofibroblast cell population maintained in conventional 2-D tissue culture; (ii) to identify key molecular properties of the α and β subunits of these Na(+) channel(s); (iii) to define the biophysical and pharmacological properties of this INa; (iv) to integrate the available multi-disciplinary data, and attempt to illustrate its functional consequences, using a mathematical model in which the human atrial myocyte is coupled via connexins to fixed numbers of fibroblasts/myofibroblasts in a syncytial arrangement. Our experimental findings confirm that a significant fraction (approximately 40-50%) of these human atrial myofibroblasts can express INa. However, our data suggest that INa may be generated by a combination of Nav 1.9, Nav 1.2, and Nav 1.5. Our results, when complemented with mathematical modeling, provide a background for re-evaluating pharmacological management of supraventricular rhythm disorders, e.g., persistent atrial fibrillation.

Indexed as

atrial arrhythmiasfibroblastmathematical modelsmyofibroblastNa+ current

Identifiers

PMID25147525
PMCPMC4124488
OpenAlexW1980369595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.